Z-Dab(Boc)-OH.DCHA

Z-Dab(Boc)-OH.DCHA is a protected amino acid derivative built on the chiral 2,4-diaminobutyric acid (Dab) backbone, presented as the dihydrochloride salt with dicyclohexylamine (DCHA). The molecule contains a benzyloxycarbonyl (Z) carbamate on one amino functionality and a Boc (tert-butoxycarbonyl) protecting group on the second, alongside a free carboxylic acid that enables amide formation in peptide coupling chemistry. Salt formation and dual N-protection modulate nucleophilicity and solubility, supporting controlled deprotection and stepwise functionalization without premature side reactions. The orthogonal protecting-group set and defined stereochemical identity make the compound a chiral amino acid intermediate suitable for preparing protected peptide building blocks and downstream Dab-based analogs.

1. Protected Amino Acid Synthesis

Z-Dab(Boc)-OH.DCHA supports protected amino acid synthesis workflows where orthogonal N-protection is required to preserve one amino group during selective coupling or derivatization. Z and Boc groups provide differential stability under common peptide synthesis conditions, while the free carboxylic acid participates in activated ester or coupling reagent-mediated amide bond formation. Salt-associated handling can improve reproducibility of weighings and intermediate preparation when working with diamino acid substrates. Downstream, the compound can be converted into Dab-containing peptide fragments and other protected amino acid intermediates used in fine chemical synthesis and process chemistry.

2. Peptide Synthesis

Z-Dab(Boc)-OH.DCHA is suitable for peptide building block preparation in solid-phase or solution-phase peptide synthesis targeting Dab-containing sequences. The dual protected amines reduce undesired crosslinking and side reactions during chain assembly, while the carboxylic acid enables peptide coupling at the C-terminus of the incorporated residue. Z/Boc orthogonality supports staged deprotection strategies that can reveal one amino functionality for subsequent conjugation or branching while maintaining the other for controlled incorporation. The resulting Dab-containing peptides and peptide fragments can be used to generate structure-activity relationship libraries and peptidomimetic scaffolds where diamino side chains influence binding and conformational properties.

3. Bioconjugation Chemistry

Z-Dab(Boc)-OH.DCHA can be applied in bioconjugation and chemical biology workflows that require controlled exposure of diamino functionality for selective attachment. The protected amines help manage chemoselectivity during the coupling of the amino acid into peptide handles, linkers, or reactive intermediates before final deprotection. The free carboxylic acid functionality enables formation of amide-linked conjugates or attachment to carrier proteins via standard coupling chemistries after appropriate activation. Dab-derived conjugates prepared from this intermediate can serve as linker units for biomolecule labeling, affinity probes, and multivalent constructs used in biochemical research.

4. Side-Chain Functionalization

Z-Dab(Boc)-OH.DCHA enables side-chain functionalization strategies that exploit the diamino acid architecture while maintaining orthogonal protection control. Z and Boc groups allow stepwise deprotection so that one amino group can be selectively transformed into nucleophilic derivatives, such as acylated, alkylated, or further protected functionalities, without scrambling the other amine. The chiral Dab backbone supports stereochemically defined intermediates for generating amino acid derivatives used in SAR studies and molecular design campaigns. Functionalized Dab products derived from this intermediate can be used to tune charge distribution, hydrogen-bonding patterns, and reactivity profiles in peptide analogs and synthetic organic chemistry.

5. Pharmaceutical Manufacturing

Z-Dab(Boc)-OH.DCHA is relevant to pharmaceutical manufacturing and specialty chemical production as a protected amino acid intermediate for constructing defined peptidic or peptidomimetic intermediates. The presence of orthogonally protected amines and a free carboxylic acid aligns with manufacturing routes that require controlled deprotection sequences and minimized side reactions during scale-up. Salt formation with DCHA can support handling characteristics for reproducible intermediate preparation and downstream purification strategies in chemical manufacturing settings. Dab-based intermediates produced from this material can feed into controlled synthesis of drug-like scaffolds, including peptide fragments and linker units used in process chemistry and fine chemical synthesis.

1. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis

3. Exosomes-mediated Transfer of miR-125a/b in Cell-to-cell Communication: A Novel Mechanism of Genetic Exchange in the Intestinal Microenvironment

4. High fat diet and GLP-1 drugs induce pancreatic injury in mice

5. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation